Literature DB >> 21424766

Current perspectives on Gleason grading of prostate cancer.

Kenneth A Iczkowski1, M Scott Lucia.   

Abstract

The 5-tier Gleason grading system for prostate cancer, introduced in 1966, has been proven to be one of the main independent predictors of prostate cancer outcome. This review addresses interobserver concordance in Gleason grading; the persistence of grading discrepancies with frequent upgrading from the biopsy to the prostatectomy specimen; the 2005 International Society of Urologic Pathologists' modifications to Gleason grading; the impact of this modified grading on grade migration and outcome prediction; and molecular correlates of cancer morphology. Data from the most recent years are emphasized.

Entities:  

Mesh：

Year:  2011        PMID： 21424766     DOI： 10.1007/s11934-011-0181-5

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN： 1527-2737            Impact factor:   3.092


  53 in total

1.  Interobserver reproducibility of Gleason grading of prostatic carcinoma: general pathologist.

Authors:  W C Allsbrook; K A Mangold; M H Johnson; R B Lane; C G Lane; J I Epstein
Journal:  Hum Pathol       Date:  2001-01       Impact factor: 3.466

2.  Updated protocol for the examination of specimens from patients with carcinomas of the prostate gland: a basis for checklists. Cancer Committee.

Authors:  J R Srigley; M B Amin; D G Bostwick; D J Grignon; M E Hammond
Journal:  Arch Pathol Lab Med       Date:  2000-07       Impact factor: 5.534

3.  Current practice of Gleason grading among genitourinary pathologists.

Authors:  Lars Egevad; William C Allsbrook; Jonathan I Epstein
Journal:  Hum Pathol       Date:  2005-01       Impact factor: 3.466

4.  The significance of modified Gleason grading of prostatic carcinoma in biopsy and radical prostatectomy specimens.

Authors:  Burkhard Helpap; Lars Egevad
Journal:  Virchows Arch       Date:  2006-11-08       Impact factor: 4.064

Review 5.  The pathologist as optimist: cancer grade deflation in prostatic needle biopsies.

Authors:  K A Iczkowski; D G Bostwick
Journal:  Am J Surg Pathol       Date:  1998-10       Impact factor: 6.394

6.  Survival rates of patients with prostatic cancer, tumor stage, and differentiation--preliminary report.

Authors:  J C Bailar; G T Mellinger; D F Gleason
Journal:  Cancer Chemother Rep       Date:  1966-03

7.  A web-based tutorial improves practicing pathologists' Gleason grading of images of prostate carcinoma specimens obtained by needle biopsy: validation of a new medical education paradigm.

Authors:  J D Kronz; M A Silberman; W C Allsbrook; J I Epstein
Journal:  Cancer       Date:  2000-10-15       Impact factor: 6.860

8.  Percentage of Gleason pattern 4 and 5 predicts survival after radical prostatectomy.

Authors:  Liang Cheng; Darrell D Davidson; Haiqun Lin; Michael O Koch
Journal:  Cancer       Date:  2007-11-01       Impact factor: 6.860

9.  Gleason score as predictor of clinicopathologic findings and biochemical (PSA) progression following radical prostatectomy.

Authors:  Marbele S Guimaraes; Maisa M Quintal; Luciana R Meirelles; Luis A Magna; Ubirajara Ferreira; Athanase Billis
Journal:  Int Braz J Urol       Date:  2008 Jan-Feb       Impact factor: 1.541

10.  Gleason score and lethal prostate cancer: does 3 + 4 = 4 + 3?

Authors:  Jennifer R Stark; Sven Perner; Meir J Stampfer; Jennifer A Sinnott; Stephen Finn; Anna S Eisenstein; Jing Ma; Michelangelo Fiorentino; Tobias Kurth; Massimo Loda; Edward L Giovannucci; Mark A Rubin; Lorelei A Mucci
Journal:  J Clin Oncol       Date:  2009-05-11       Impact factor: 44.544
View more
  15 in total

1.  Automated prostate tissue referencing for cancer detection and diagnosis.

Authors:  Jin Tae Kwak; Stephen M Hewitt; André Alexander Kajdacsy-Balla; Saurabh Sinha; Rohit Bhargava
Journal:  BMC Bioinformatics       Date:  2016-06-01       Impact factor: 3.169

2.  Adult murine prostate basal and luminal cells are self-sustained lineages that can both serve as targets for prostate cancer initiation.

Authors:  Nahyun Choi; Boyu Zhang; Li Zhang; Michael Ittmann; Li Xin
Journal:  Cancer Cell       Date:  2012-02-14       Impact factor: 31.743

3.  Increased bisecting N-acetylglucosamine and decreased branched chain glycans of N-linked glycoproteins in expressed prostatic secretions associated with prostate cancer progression.

Authors:  Julius O Nyalwidhe; Lucy R Betesh; Thomas W Powers; E Ellen Jones; Krista Y White; Tanya C Burch; Jasmin Brooks; Megan T Watson; Raymond S Lance; Dean A Troyer; O John Semmes; Anand Mehta; Richard R Drake
Journal:  Proteomics Clin Appl       Date:  2013-09-13       Impact factor: 3.494

4.  Exploration on Gleason score variation trend of patients with prostate carcinoma from 1996 to 2019: a retrospective single center study.

Authors:  Weiyu Zhang; Gongwei Wang; Fengling Lan; Huanrui Wang; Danhua Shen; Kexin Xu; Tao Xu; Hao Hu
Journal:  Gland Surg       Date:  2021-02

5.  Cancer detection and biopsy classification using concurrent histopathological and metabolomic analysis of core biopsies.

Authors:  Meredith V Brown; Jonathan E McDunn; Philip R Gunst; Elizabeth M Smith; Michael V Milburn; Dean A Troyer; Kay A Lawton
Journal:  Genome Med       Date:  2012-04-30       Impact factor: 11.117

6.  Markers of field cancerization: proposed clinical applications in prostate biopsies.

Authors:  Kristina A Trujillo; Anna C Jones; Jeffrey K Griffith; Marco Bisoffi
Journal:  Prostate Cancer       Date:  2012-05-14

7.  Increased aPKC Expression Correlates with Prostatic Adenocarcinoma Gleason Score and Tumor Stage in the Japanese Population.

Authors:  Anthony S Perry; Bungo Furusato; Raymond B Nagle; Sourav Ghosh
Journal:  Prostate Cancer       Date:  2014-04-29

8.  Optimized b-value selection for the discrimination of prostate cancer grades, including the cribriform pattern, using diffusion weighted imaging.

Authors:  Sarah L Hurrell; Sean D McGarry; Amy Kaczmarowski; Kenneth A Iczkowski; Kenneth Jacobsohn; Mark D Hohenwalter; William A Hall; William A See; Anjishnu Banerjee; David K Charles; Marja T Nevalainen; Alexander C Mackinnon; Peter S LaViolette
Journal:  J Med Imaging (Bellingham)       Date:  2017-10-27

9.  Expression of the TPα and TPβ isoforms of the thromboxane prostanoid receptor (TP) in prostate cancer: clinical significance and diagnostic potential.

Authors:  Eamon P Mulvaney; Christine Shilling; Sarah B Eivers; Antoinette S Perry; Anders Bjartell; Elaine W Kay; R William Watson; B Therese Kinsella
Journal:  Oncotarget       Date:  2016-11-08

10.  Feature-based analysis of mouse prostatic intraepithelial neoplasia in histological tissue sections.

Authors:  Pekka Ruusuvuori; Mira Valkonen; Matti Nykter; Tapio Visakorpi; Leena Latonen
Journal:  J Pathol Inform       Date:  2016-01-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.